Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2021

Jun 17, 2021

29875_dirs_2021-06-17_91c85fe8-ac51-4387-81b7-648d7820a32d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-06-15

Reporting Person: Brennan Troyen A (EVP and Chief Medical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-06-15 Common Stock M 65681 $62.21 Acquired 210378.059 Direct
2021-06-15 Common Stock S 67552 $86.00 Disposed 142826.059 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-06-15 Stock Option $62.21 M 65681 Disposed 2025-04-01 Common Stock (65681) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock (restricted) 4805 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $102.26 2022-04-01 Common Stock (47937) 47937 Direct
Stock Option $104.82 2023-04-01 Common Stock (53772) 53772 Direct
Stock Option $78.05 2024-04-03 Common Stock (75134) 75134 Direct
Stock Option $54.19 2029-04-01 Common Stock (161605) 161605 Direct
Stock Option $58.34 2030-04-01 Common Stock (112637) 112637 Direct
Stock Option $74.30 2031-04-01 Common Stock (99344) 99344 Direct

Footnotes

F1: All sales were effected pursuant to a Rule 10b5-1 plan.

F2: Option became exercisable in four equal annual installments, commencing 4/1/2019.

F3: Option became exercisable in four equal annual installments, commencing 4/1/2016.

F4: Option became exercisable in four equal annual installments, commencing 4/1/2017.

F5: Option became exercisable in four equal annual installments, commencing 4/3/2018.

F6: Option became exercisable in four equal annual installments, commencing 4/1/2020.

F7: The number of shares subject to the option were calculated using a 30-day average price.

F8: Options became exercisable in four equal annual installments, commencing 4/1/2021.

F9: Option becomes exercisable in four equal annual installments, commencing 4/1/2022.